126 related articles for article (PubMed ID: 2360470)
1. Effects of HA1077, a novel calciumantagonistic spasmolytic agent on intracerebral arterioles of rats.
Takayasu M; Dacey RG
Acta Neurochir (Wien); 1990; 103(1-2):67-70. PubMed ID: 2360470
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of a novel antivasospasm drug, HA1077.
Asano T; Ikegaki I; Satoh S; Suzuki Y; Shibuya M; Takayasu M; Hidaka H
J Pharmacol Exp Ther; 1987 Jun; 241(3):1033-40. PubMed ID: 3598899
[TBL] [Abstract][Full Text] [Related]
3. Effects of calcium antagonists on intracerebral penetrating arterioles in rats.
Takayasu M; Bassett JE; Dacey RG
J Neurosurg; 1988 Jul; 69(1):104-9. PubMed ID: 3379464
[TBL] [Abstract][Full Text] [Related]
4. Blockade of intracellular actions of calcium may protect against ischaemic damage to the gerbil brain.
Asano T; Ikegaki I; Satoh S; Mochizuki D; Hidaka H; Suzuki Y; Shibuya M; Sugita K
Br J Pharmacol; 1991 Aug; 103(4):1935-8. PubMed ID: 1912980
[TBL] [Abstract][Full Text] [Related]
5. Effects of mannitol on intracerebral arteriolar diameter in vitro: extraluminal and intraluminal application.
Takayasu N; Dacey RG
Neurosurgery; 1989 Nov; 25(5):747-51; discussion 751-2. PubMed ID: 2511500
[TBL] [Abstract][Full Text] [Related]
6. Effects of HA1077, an intracellular calcium antagonist, on neurotransmitter metabolism in rat brain in vivo.
Kondoh Y; Mizusawa S; Murakami M; Nagata K; Nakamichi H; Watanabe K
Metab Brain Dis; 1991 Sep; 6(3):111-24. PubMed ID: 1779923
[TBL] [Abstract][Full Text] [Related]
7. Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase.
Asano T; Suzuki T; Tsuchiya M; Satoh S; Ikegaki I; Shibuya M; Suzuki Y; Hidaka H
Br J Pharmacol; 1989 Dec; 98(4):1091-100. PubMed ID: 2611484
[TBL] [Abstract][Full Text] [Related]
8. Effects of isoquinoline derivatives, HA1077 and H-7, on cytosolic Ca2+ level and contraction in vascular smooth muscle.
Takizawa S; Hori M; Ozaki H; Karaki H
Eur J Pharmacol; 1993 Dec; 250(3):431-7. PubMed ID: 8112403
[TBL] [Abstract][Full Text] [Related]
9. HA1077, a novel calcium antagonistic antivasospasm drug, increases both cerebral blood flow and glucose metabolism in conscious rats.
Sako K; Tsuchiya M; Yonemasu Y; Asano T
Eur J Pharmacol; 1991 Dec; 209(1-2):39-43. PubMed ID: 1814759
[TBL] [Abstract][Full Text] [Related]
10. Endothelin: a potential modulator of cerebral vasospasm.
Asano T; Ikegaki I; Satoh S; Suzuki Y; Shibuya M; Sugita K; Hidaka H
Eur J Pharmacol; 1990 Nov; 190(3):365-72. PubMed ID: 2272374
[TBL] [Abstract][Full Text] [Related]
11. Possible prophylactic potential of HA1077, a Ca2+ channel antagonist and vasodilator, on chronic cerebral vasospasm.
Satoh S; Suzuki Y; Harada T; Ikegaki I; Asano T; Shibuya M; Sugita K; Hidaka H
Eur J Pharmacol; 1992 Sep; 220(2-3):243-8. PubMed ID: 1425995
[TBL] [Abstract][Full Text] [Related]
12. A new type of vasodilator, HA1077, an isoquinoline derivative, inhibits proliferation of bovine vascular smooth muscle cells in culture.
Shirotani M; Yui Y; Hattori R; Kawai C
J Pharmacol Exp Ther; 1991 Nov; 259(2):738-44. PubMed ID: 1941621
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of myosin light chain phosphorylation in cultured smooth muscle cells by HA1077, a new type of vasodilator.
Sasaki Y; Sasaki Y
Biochem Biophys Res Commun; 1990 Sep; 171(3):1182-7. PubMed ID: 2222437
[TBL] [Abstract][Full Text] [Related]
14. The effects of HA compound calcium antagonists on delayed cerebral vasospasm in dogs.
Takayasu M; Suzuki Y; Shibuya M; Asano T; Kanamori M; Okada T; Kageyama N; Hidaka H
J Neurosurg; 1986 Jul; 65(1):80-5. PubMed ID: 3712031
[TBL] [Abstract][Full Text] [Related]
15. Effects of HA1077, a protein kinase inhibitor, on myosin phosphorylation and tension in smooth muscle.
Seto M; Sasaki Y; Hidaka H; Sasaki Y
Eur J Pharmacol; 1991 Mar; 195(2):267-72. PubMed ID: 1874276
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of myosin phosphorylation and tension of hyperplastic arteries by the kinase inhibitor HA1077.
Seto M; Shindo K; Ito K; Sasaki Y
Eur J Pharmacol; 1995 Mar; 276(1-2):27-33. PubMed ID: 7781692
[TBL] [Abstract][Full Text] [Related]
17. The effects of an intracellular calcium antagonist HA 1077 on delayed cerebral vasospasm in dogs.
Shibuya M; Suzuki Y; Takayasu M; Asano T; Harada T; Ikegaki I; Satoh S; Hidaka H
Acta Neurochir (Wien); 1988; 90(1-2):53-9. PubMed ID: 3344625
[TBL] [Abstract][Full Text] [Related]
18. Compared effects of calcium entry blockers on calcium-induced tension in rat isolated cerebral and peripheral resistance vessels.
Julou-Schaeffer G; Freslon JL
Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):670-6. PubMed ID: 3444482
[TBL] [Abstract][Full Text] [Related]
19. Involvement of specific receptors and calcium mechanisms in serotonergic contractile response of isolated cerebral and peripheral arteries from rats.
Chang JY; Owman C
J Pharmacol Exp Ther; 1987 Aug; 242(2):629-36. PubMed ID: 3612555
[TBL] [Abstract][Full Text] [Related]
20. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
